Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaust Limited ( (AU:NUZ) ) has provided an update.
Neurizon Therapeutics Limited has announced a proposed issue of 43,333,334 ordinary fully paid securities, with the issuance date set for September 24, 2025. This move, disclosed to the ASX, is part of their strategic financial operations, potentially impacting their market positioning and stakeholder interests.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.52 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Average Trading Volume: 305,562
Technical Sentiment Signal: Sell
Current Market Cap: A$68.92M
Learn more about NUZ stock on TipRanks’ Stock Analysis page.